Resveratrol inhibits cell proliferation and induces apoptosis of human breast carcinoma MCF-7 cells

Oncology Reports

Volumn 11, Issue 2, 2004, Pages 441-446

  Kim, Young Ae ^a,b   Choi, Byung Tae ^a   Lee, Yong Tae ^a   Il Park, Dong ^a   Rhee, Sook Hee ^b   Park, Kun Young ^b   Choi, Yung Hyun ^a  

^a Dong Eui University   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

Apoptosis; Breast carcinoma; MCF 7 cells; Resveratrol

Indexed keywords

ANTINEOPLASTIC AGENT; PRIMER DNA; RESVERATROL; STILBENE DERIVATIVE; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; BREAST TUMOR; CELL CYCLE; CELL DIVISION; DRUG EFFECT; FEMALE; GENETICS; GRAPE; HUMAN; PHYTOTHERAPY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WINE;

ANTICARCINOGENIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; DNA PRIMERS; FEMALE; HUMANS; NEOPLASM PROTEINS; PHYTOTHERAPY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STILBENES; VITIS; WINE;

EID: 3242815537     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.2.441     Document Type: Article

References (39)

1. Zenebe W and Pechanova O: Effects of red wine polyphenolic compounds on the cardiovascular system. Bratisl Lek Listy 103: 159-165, 2002.
2. Gee JM and Johnson IT: Polyphenolic compounds: interactions with the gut and implications for human health. Curr Med Chem 8: 1245-1255, 2001. (Pubitemid 32791795)
3. Sun AY, Simonyi A and Sun GY: The 'French paradox' and beyond: neuroprotective effects of polyphenols. Free Radic Biol Med 32: 314-318, 2002. (Pubitemid 34159085)
4. Bhat KPL, Kosmeder JW II and Pezzuto JM: Biological effects of resveratrol. Antioxid Redox Signal 3: 1041-1064, 2001. (Pubitemid 34027361)
5. Chan MM: Antimicrobial effect of resveratrol on dermatophytes and bacterial pathogens of the skin. Biochem Pharmacol 63: 99-104, 2002.
6. Russo P, Tedesco I, Russo M, Russo GL, Venezia A and Cicala C: Effects of de-alcoholated red wine and its phenolic fractions on platelet aggregation. Nutr Metab Cardiovasc Dis 11: 25-29, 2001. (Pubitemid 33687791)
7. Wang Z, Huang Y, Zou J, Cao K, Xu Y and Wu JM: Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro. Int J Mol Med 9: 77-79, 2002.
8. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G and Goldberg DM: The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 235: 207-219, 1995.
9. Brito P, Almeida LM and Dinis TC: The interaction of resveratrol with ferrylmyoglobin and peroxynitrite; protection against LDL oxidation. Free Radic Res 36: 621-631, 2002. (Pubitemid 34567335)
10. Roldan A, Palacios V, Caro I and Perez L: Resveratrol content of Palomino fino grapes: influence of vintage and fungal infection. J Agric Food Chem 51: 1464-1468, 2003.
11. Roemer K and Mahyar-Roemer M: The basis for the chemopreventive action of resveratrol. Drugs Today 38: 571-580, 2002.
12. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC and Pezzuto JM: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220, 1997. (Pubitemid 127696281)
13. Uenobe F, Nakamura S and Miyazawa M: Antimutagenic effect of resveratrol against Trp-P-1. Mutat Res 373: 197-200, 1997. (Pubitemid 27478863)
14. Ahmad N, Adhami VM, Afaq F, Feyes DK and Mukhtar H: Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res 7: 1466-1473, 2001. (Pubitemid 32708704)
15. Bernhard D, Tinhofer I, Tonko M, Hubl H, Ausserlechner MJ, Greil R, Kofler R and Csordas A: Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells. Cell Death Differ 7: 834-842, 2000.
16. Joe AK, Liu H, Suzui M, Vural ME, Xiao D and Weinstein IB: Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res 8: 893-903, 2002. (Pubitemid 34742123)
17. Park JW, Choi YJ, Jang MA, Lee YS, Jun DY, Suh SI, Baek WK, Suh MH, Jin IN and Kwon TK: Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U937 cells. Cancer Lett 163: 43-49, 2001. (Pubitemid 32121829)
18. Ragione FD, Cucciolla V, Borriello A, Pietra VD, Racioppi L, Soldati G, Manna C, Galletti P and Zappia V: Resveratrol arrests the cell division cycle at S/G2 phase transition. Biochem Biophys Res Commun 250: 53-58, 1998. (Pubitemid 28448621)
19. Ferry-Dumazet H, Garnier O, Mamani-Matsuda M, Vercauteren J, Belloc F, Billiard C, Dupouy M, Thiolat D, Kolb JP, Marit G, Reiffers J and Mossalayi MD: Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells. Carcinogenesis 23: 1327-1333, 2002.
20. Surh YJ, Hurh YJ, Kang JY, Lee E, Kong G and Lee SJ: Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Lett 140: 1-10, 1999. (Pubitemid 29251307)
21. Clement MV, Hirpara JL, Chawdhury SH and Pervaiz S: Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92: 996-1002, 1998. (Pubitemid 28355484)
22. Li F, Srinivasan A, Wang Y, Armstrong RC and Tomaselli KJ: Cell-specific induction of apoptosis by microinjection of cytochrome c. J Biol Chem 272: 30299-30305, 1997.
23. Janicke RU, Sprengart ML, Wati MR and Porter AG: Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 273: 9357-9360, 1998. (Pubitemid 28183012)
24. Carmichael J, DeGraff WG, Gazdar AF, Minna JD and Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936-942, 1978.
25. Choi YH, Lee SJ, Nguyen P, Jang JS, Lee J, Wu ML, Takano E, Maki M, Henkart PA and Trepel JB: Regulation of cyclin D1 by calpain protease. J Biol Chem 272: 28479-28484, 1997. (Pubitemid 27517796)
26. Stewart ZA, Westfall MD and Pietenpol JA: Cell-cycle dysregulation and anticancer therapy. Trends Pharmacol Sci 24: 139-145, 2003. (Pubitemid 36293780)
27. Schultz LB, Chehab NH, Malikzay A, DiTullio RA Jr, Stavridi ES and Halazonetis TD: The DNA damage checkpoint and human cancer. Cold Spring Harb Symp Quant Biol 65: 489-498, 2000. (Pubitemid 32611973)
28. Vermeulen K, van Bockstaele DR and Berneman ZN: The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 36: 131-149, 2003. (Pubitemid 36808270)
29. Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM and Pagano M: Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 15: 2612-2624, 1995.
30. Girard F, Strausfeld U, Fernandez A and Lamb NJ: Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67: 1169-1179, 1991. (Pubitemid 121001529)
31. Gartel AL and Tyner AL: The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 1: 639-649 2002.
32. Ball KL: p21: structure and functions associated with cyclin-CDK binding. Prog Cell Cycle Res 3: 125-134, 1997.
33. Hockenbery DM, Giedt CD, O'Neill JW, Manion MK and Banker DE: Mitochondria and apoptosis: new therapeutic targets. Adv Cancer Res 85: 203-242, 2002.
34. MacCarthy-Morrogh L, Mouzakiti A, Townsend P, Brimmell M and Packham G: Bcl-2-related proteins and cancer. Biochem Soc Trans 27: 785-789, 1999. (Pubitemid 30032127)
35. Salomons GS, Brady HJ, Verwijs-Janssen M, van den Berg JD, Hart AA, van den Berg H, Behrendt H, Hahlen K and Smets LA: The Bax alpha: Bcl-2 ratio modulates the response to dexamethasone in leukaemic cells and is highly variable in childhood acute leukaemia. Int J Cancer 71: 959-965, 1997. (Pubitemid 27252876)
36. Cohen GM: Caspases: the executioners of apoptosis. Biochem J 326: 1-16, 1997.
37. Sun XM, MacFarlane M, Zhuang J, Wolf BB, Green DR and Cohen GM: Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem 274: 5053-5060, 1999.
38. Dorrie J, Gerauer H, Wachter Y and Zunino SJ: Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. Cancer Res 61: 4731-4739, 2001. (Pubitemid 32691883)
39. Dumont C, Durrbach A, Bidere N, Rouleau M, Kroemer G, Bernard G, Hirsch F, Charpentier B, Susin SA and Senik A: Caspase-independent commitment phase to apoptosis in activated blood T lymphocytes: reversibility at low apoptotic insult. Blood 96: 1030-1038, 2000. (Pubitemid 30616870)